Compare · AMED vs NAKA
AMED vs NAKA
Side-by-side comparison of Amedisys Inc (AMED) and Nakamoto Inc. (NAKA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMED and NAKA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- AMED is the larger of the two at $4.20B, about 32.8x NAKA ($128.1M).
- NAKA has hit the wire 14 times in the past 4 weeks while AMED has been quiet.
- AMED has more recent analyst coverage (25 ratings vs 3 for NAKA).
- Company
- Amedisys Inc
- Nakamoto Inc.
- Price
- $100.98-0.00%
- $7.25+1.05%
- Market cap
- $4.20B
- $128.1M
- 1M return
- -
- +54.81%
- 1Y return
- -
- -97.74%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- News (4w)
- 0
- 14
- Recent ratings
- 25
- 3
Amedisys Inc
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. As of December 31, 2020, the company owned and operated 320 home health care centers, 180 hospice care centers, and 14 personal-care care centers in 39 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Latest AMED
- SEC Form 15-12G filed by Amedisys Inc
- Twilio Set to Join S&P MidCap 400
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
Latest NAKA
- Director Yusko Mark W gave a grant of 10,623 shares, decreasing direct ownership by 44% to 13,442 units (SEC Form 4)
- Director Xethalis Gregory Elias gave a grant of 10,623 shares, decreasing direct ownership by 44% to 13,442 units (SEC Form 4)
- Director Mcnulty Perianne Boring gave a grant of 10,623 shares, decreasing direct ownership by 44% to 13,442 units (SEC Form 4)
- Director Blackburn Charles Phillip gave a grant of 10,623 shares, decreasing direct ownership by 44% to 13,442 units (SEC Form 4)
- Chief Investment Officer Evans Tyler Matthew disposed of 230 shares, acquired 3 shares and was granted 56,657 shares, increasing direct ownership by 11% to 577,746 units (SEC Form 4)
- Chief Operating Officer Fabiano Amanda was granted 70,821 shares, increasing direct ownership by 69% to 174,204 units (SEC Form 4)
- Chief Executive Officer Bailey David F disposed of 3,744 shares, acquired 3 shares and was granted 70,821 shares, increasing direct ownership by 2% to 3,252,326 units (SEC Form 4)
- Chief Executive Officer Bailey David F bought $209,990 worth of shares (36,986 units at $5.68), increasing direct ownership by 0.15% to 3,185,246 units (SEC Form 4)
- Chief Executive Officer Bailey David F bought $25,161 worth of shares (4,918 units at $5.12), increasing direct ownership by 0.15% to 3,180,394 units (SEC Form 4)
- Nakamoto Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits